BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22145604)

  • 1. The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol.
    Barceló F; De Paco C; López-Espín JJ; Silva Y; Abad L; Parrilla JJ
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):39-43. PubMed ID: 22145604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose misoprostol used in outpatient management of first trimester spontaneous abortion.
    Sifakis S; Angelakis E; Vardaki E; Fragouli Y; Koumantakis E
    Arch Gynecol Obstet; 2005 Sep; 272(3):183-6. PubMed ID: 15909189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
    Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient medical management of missed miscarriage using misoprostol.
    Shankar M; Economides DL; Sabin CA; Tan B; Kadir RA
    J Obstet Gynaecol; 2007 Apr; 27(3):283-6. PubMed ID: 17464813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised double blind trial comparing misoprostol or placebo in the management of early miscarriage.
    Blohm F; Fridén BE; Milsom I; Platz-Christensen JJ; Nielsen S
    BJOG; 2005 Aug; 112(8):1090-5. PubMed ID: 16045523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
    Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
    Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misoprostol for uterine evacuation in patients with early pregnancy failures.
    Murchison A; Duff P
    Am J Obstet Gynecol; 2004 May; 190(5):1445-6. PubMed ID: 15167864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual versus vaginal misoprostol in the management of missed miscarriage.
    Shah N; Azam SI; Khan NH
    J Pak Med Assoc; 2010 Feb; 60(2):113-6. PubMed ID: 20209697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual versus vaginal misoprostol for the management of missed abortion.
    Tanha FD; Feizi M; Shariat M
    J Obstet Gynaecol Res; 2010 Jun; 36(3):525-32. PubMed ID: 20598032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial.
    Goel A; Mittal S; Taneja BK; Singal N; Attri S
    Arch Gynecol Obstet; 2011 Jun; 283(6):1409-13. PubMed ID: 21431329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
    Murthy AS; Creinin MD; Harwood B; Schreiber C
    Contraception; 2005 May; 71(5):333-6. PubMed ID: 15854632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with misoprostol in the management of missed abortion in the second trimester.
    Menakaya U; Otoide V; Omo Aghoja L; Odunsi K; Okonofua F
    J Obstet Gynaecol; 2005 Aug; 25(6):583-5. PubMed ID: 16234145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion.
    Ganguly RP; Saha SP; Mukhopadhyay S; Bhattacharjee N; Bhattacharyya SK; Patra KK
    J Indian Med Assoc; 2010 May; 108(5):283-4, 286. PubMed ID: 21121402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual misoprostol in management of missed abortion in India.
    Sharma D; Singhal SR; Rani XX
    Trop Doct; 2007 Jan; 37(1):39-40. PubMed ID: 17326888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal misoprostol in the management of first-trimester missed abortions.
    Ayres-de-Campos D; Teixeira-da-Silva J; Campos I; Patrício B
    Int J Gynaecol Obstet; 2000 Oct; 71(1):53-7. PubMed ID: 11044543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early termination of pregnancy by single-dose 800 microg misoprostol compared with surgical evacuation.
    Prasad S; Kumar A; Divya A
    Fertil Steril; 2009 Jan; 91(1):28-31. PubMed ID: 18295212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.